InnovAge Holding Corp. (INNV) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $1.46B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Care Facilities |
| Country | US | CEO | Patrick Blair |
| IPO Date | 2021-03-04 | CAGR | 10.63% |
| Employees | 2,440 | Website | www.innovage.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.01% | Total Yield | 0.01% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $1.55B | P/E | -119.44 | Forward P/E | 26.22 | PEG | — |
| P/S | 2375324633.48 | P/B | 9732276681.59 | P/CF | 44394483954.97 | P/FCF | 57407728185.73 |
| Sales | $945.90M | Sales 1Y | 13.73% | Sales 3Y | 38.27% | Sales 5Y | 52.89% |
| EPS | $-0.09 | EPS 1Y | — | EPS 3Y | — | EPS 5Y | — |
| Sales QoQ | 5.1% | EPS QoQ | -382.41% | Sales QoQ Avg | 3.72% | EPS QoQ Avg | -146.19% |
| Gross Margin | 20.75% | Operating Margin | 3.91% | Profit Margin | -2.35% | ROCE | 10.53% |
| ROA | -4% | ROE | -9% | Altman Z Score | 4.72 | Piotroski Score | 5 |
| Current Ratio | 1.03 | Quick Ratio | 1.03 | Cash Ratio | 0.49 | Op. CF Ratio | 0.09 |
| Debt/Equity | 0.41 | Debt/Assets | 0.17 | Lt Debt/Equity | 0.36 | Lt Debt/Cap. | 0.19 |
| Intrst Cov. | 8.13 | Inventory Turnover | — | Asset Turnover | 1.73 | Receivables Turnover | 29.59 |
| Enterprise Value | $1.55B | P/E Ratio | -119.44 |
| Forward P/E | 26.22 | PEG Ratio | — |
| P/S Ratio | 2375324633.48 | P/B Ratio | 9732276681.59 |
| P/CF Ratio | 44394483954.97 | P/FCF Ratio | 57407728185.73 |
| EPS | $-0.09 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 13.73% | Gross Margin | 0.21% |
| Operating Margin | 0.04% | Profit Margin | -0.02% |
| ROE | -0.09% | ROA | -0.04% |
| ROCE | 0.11% | Current Ratio | 1.03 |
| Quick Ratio | 1.03 | Cash Ratio | 0.49 |
| Debt/Equity | 0.41 | Interest Coverage | 8.13 |
| Altman Z Score | 4.72 | Piotroski Score | 5 |
InnovAge Holding Corp. (INNV) valuation & financials
InnovAge Holding Corp. (INNV) has a market capitalization of $1.46B and trades at a price-to-earnings ratio of -119.4. It operates in the Healthcare sector (Medical - Care Facilities).
InnovAge Holding Corp.'s revenue grew +13.7% over the last year.
InnovAge Holding Corp.'s next earnings report is scheduled for September 8, 2026 after market close; analysts estimate EPS of $0.07. Check the earnings calendar to see all companies reporting this week.
InnovAge Holding Corp. (INNV) — frequently asked questions
When does InnovAge Holding Corp. (INNV) report earnings next?
InnovAge Holding Corp. is expected to report earnings on September 8, 2026 after market close. Analysts estimate EPS of $0.07.
What is InnovAge Holding Corp.'s market cap?
InnovAge Holding Corp. (INNV) has a market capitalization of $1.46B.
What is INNV's P/E ratio?
InnovAge Holding Corp. trades at a price-to-earnings ratio of -119.4, with trailing twelve-month EPS of $-0.09.
How fast is InnovAge Holding Corp. growing?
InnovAge Holding Corp.'s revenue grew +13.7% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)